This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Hope-Simpson RE (1965) The Nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9–20
Garnett GP, Grenfell BT (1992) The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 108:513–528
Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20:2500–2507
Ogunjimi B, Van Damme P, Beutels P (2013) Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One 8:e66485. https://doi.org/10.1371/journal.pone.0066485
Gershon AA (2017) Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future? J Infect 74:S27–S33. https://doi.org/10.1016/s0163-4453(17)30188-3
Ogunjimi B, Van den Bergh J, Meysman P (2017) Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. https://doi.org/10.1038/s41598-017-01024-8
Harder T, Siedler A (2018) Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster a quantitative view on the exogenous boosting hypothesis. Clin Infect Dis Off Publ Infect Dis Soc Am 9:9. https://doi.org/10.1093/cid/ciy1099
Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB (2019) Trends in US community hospitalizations due to herpes zoster: 2001–2015. Vaccine 37:882–888. https://doi.org/10.1016/j.vaccine.2018.12.034
Hales CM, Harpaz R, Joesoef MR, Bialek SR (2013) Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 159:739. https://doi.org/10.7326/0003-4819-159-11-201312030-00006
Kawai K, Yawn BP, Wollan P, Harpaz R (2016) Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis 63:221–226
Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P (2009) Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc 84:787–794. https://doi.org/10.1016/s0025-6196(11)60488-6
White RR, Lenhart G, Singhal PK et al (2009) Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 27:781–792. https://doi.org/10.2165/11317560-000000000-00000
Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ (2016) Healthcare resource utilization and costs associated with herpes zoster in the US. J Med Econ 19:928–935. https://doi.org/10.1080/13696998.2016.1187150
Meyers JL, Madhwani S, Rausch D, Candrilli SD, Krishnarajah G, Yan S (2017) Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccines Immunother 13:1861–1872. https://doi.org/10.1080/21645515.2017.1324373
Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S (2017) Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis 17:69. https://doi.org/10.1186/s12879-017-2185-3
TrendWatch Chartbook 2018: Trends affecting hospitals and health systems. American Hospital Association; 2018. https://www.aha.org. Accessed 19 Apr 2019
Conflict of interest
The authors declare that they have no conflict of interest.
This manuscript does not report on activities requiring ethics approval, including research involving human participants or animals.
Not applicable; this manuscript does not report on procedures performed in studies involving human participants.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Saade, E.A., Canaday, D.H., Davidson, H.E. et al. VZV-containing vaccines and hospitalization for herpes zoster: careful optimism. Aging Clin Exp Res 31, 1347–1348 (2019). https://doi.org/10.1007/s40520-019-01264-w